Bioinformatics Market (Product: Bioinformatics Platforms, Bioinformatics Services, Knowledge Management Tools, Biocontent; By Application: Genomics, Molecular Phylogenetics, Metabolomics, Proteomics, Transcriptions, Chemoinformatics and Drug Designing, Others; By Sector: Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology, Other Sectors) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global bioinformatics market size is projected to surpass around US$ 42.90 billion by 2032 from US$ 13.27 billion in 2022, progressing at a CAGR of 12.50% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. bioinformatics market size is expected to hit around US$ 11.23 billion by 2032 from US$ 3.47 billion in 2022, progressing at a CAGR of 12.50% during the forecast period 2023 to 2032.
North America dominated the bioinformatics market in 2022. The bioinformatics market in North America is growing due to the favorable government regulations in favor of market players. In addition, the growth of North America bioinformatics market is also attributed to the existence of major market players. The government of the U.S. is investing towards the development of bioinformatics market. Furthermore, expanding research and development activities are paving way for the expansion of bioinformatics market in the region.
Europe, on the other hand, is expected to develop at the fastest rate during the forecast period. The UK, Italy, and France dominate the bioinformatics market in Europe region. The growing investments in healthcare sector are driving the growth of Europe bioinformatics market. Moreover, the adoption of innovative technologies such as artificial intelligence and internet of things are contributing towards the growth of bioinformatics market in Europe. The market players operating in Europe bioinformatics market are adopting strategies such as partnership and acquisition.
The combination of biology and information technology is known as bioinformatics. Various tools and software are used in bioinformatics such as data management, data creation, data warehousing, and data mining. The market for bioinformatics is growing due to the expansion of pharmaceutical sector. The pharmaceutical industry in Europe was valued at $139,287 million in 2000 as per the European Federation of Pharmaceutical Industries and Associations’ statistics of 2019, and it climbed to $284,028 million in 2018. In addition, due to various benefits provided by bioinformatics is driving the market growth.
The COVID-19 pandemic had a positive impact on the growth of global bioinformatics market. The early detection of virus using bioinformatics opened new growth opportunities for global bioinformatics market. The bioinformatics were also used for the development of drugs and vaccines. Moreover, various strategic alliances were formed during COVID-19 pandemic in global bioinformatics market. The UK government, for example, announced the COVID-19 Genomics UK Consortium in March 2020 with a $21 million investment to sequence the genomes of SARS-CoV-2, the virus involved during COVID-19 epidemic, using genome sequencing. The Public Health Agencies and the NHS and a number of research institutes make up the COVID-19 Genomics UK Consortium.
Another factor boosting the growth of global bioinformatics market is growing investments in biology and information technology sectors. Moreover, government all around the world is taking constant efforts for the development of global bioinformatics market. The bioinformatics tools and software are mostly used for cutting down the extra cost and expenses related to drug development process. This factor is supporting the growth of global bioinformatics market.
On the other hand, the growth of global bioinformatics market is being restricted by lack of skilled professionals and lack of resources in developing economy. Moreover, the use of alternative tools will also hinder the expansion of global bioinformatics market.
To offer latest and new products and maintain their market positions around the globe, major market players in the global bioinformatics market are using various methods such as collaborations and acquisitions with other organizations. The key market players are collaborating to develop a next-generation sequencing based assay that assesses cancer relevant genetic changes using RNA and DNA produced from a patient’s tumor in a single process.
Furthermore, the release of technologically developed bioinformatics tools and software such as AUTODOCK, BALL, and RasMol as well as increased market utilization of these tools for accurate and precise analysis of biomarkers discovery programs that aid in contamination sensing during the early stages of the drug development process are expected to propel the growth of global bioinformatics market.
| Report Coverage | Details |
| Market Size by 2032 | USD 42.90 Billion |
| Growth Rate from 2023 to 2032 |
CAGR of 12.50% |
| Largest Market | North America |
| Fastest Growing Market | Europe |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Product, Application, Sector, Geography |
| Companies Mentioned | Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN N.V., Agilent Technologies Inc., Illumina Inc., Waters Corporation, NeoGenomics Laboratories, Perkin Elmer Inc., Fios Genomics, and Source BioScience |
The bioinformatics services segment dominated the bioinformatics market in 2022. The factors such as growing initiatives regarding research and development as well as surge in demand for novel drugs are boosting the growth of bioinformatics services segment. Furthermore, the technological advancements are resulting into the growing demand for bioinformatics services in the global market.
The bioinformatics platforms segment is fastest growing segment of the bioinformatics market in 2020. The growing usage of various tools for database management is driving the growth of bioinformatics platforms. The high utilization of next generation sequencing is also contributing to the growth of bioinformatics platforms. In addition, the growing demand for exome and genome technologies is driving the segment growth.
The genomic segment dominated the bioinformatics market in 2022. The demand for bioinformatics is growing in genomics due to adoption of new and innovative technologies. The bioinformatics in pharmacogenomics are used for handling and managing large amount of data and information in database. The sequencing technology is widely used in drug development process. This is directly impacting the growth of genomic segment over the forecast period.
The proteomics segment is fastest growing segment of the bioinformatics market in 2020. The growth of proteomics segment is attributed to the rising research and development initiatives and high investments for the development of technologies. These technologies help to analyze and manage data on a large scale. Moreover, algorithms are also used for managing and monitoring data in database. All these factors are driving the growth of the proteomics segment.
Key Developments
Segments Covered in the Report
(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)
By Product
By Application
By Sector
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioinformatics Market
5.1. COVID-19 Landscape: Bioinformatics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioinformatics Market, By Product
8.1. Bioinformatics Market, by Product, 2023-2032
8.1.1 Bioinformatics Platforms
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Bioinformatics Services
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Knowledge Management Tools
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Biocontent
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Bioinformatics Market, By Sector
9.1. Bioinformatics Market, by Sector, 2023-2032
9.1.1. Medical Biotechnology
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Animal Biotechnology
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Plant Biotechnology
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Environmental Biotechnology
9.1.4.1. Market Revenue and Forecast (2020-2032)
9.1.5. Forensic Biotechnology
9.1.5.1. Market Revenue and Forecast (2020-2032)
9.1.6. Other Sectors
9.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Bioinformatics Market, By Application
10.1. Bioinformatics Market, by Application, 2023-2032
10.1.1. Genomics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Molecular Phylogenetics
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Metabolomics
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Proteomics
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Transcriptions
10.1.5.1. Market Revenue and Forecast (2020-2032)
10.1.6. Chemoinformatics and Drug Designing
10.1.6.1. Market Revenue and Forecast (2020-2032)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Bioinformatics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Sector (2020-2032)
11.1.3. Market Revenue and Forecast, by Application (2020-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.4.2. Market Revenue and Forecast, by Sector (2020-2032)
11.1.4.3. Market Revenue and Forecast, by Application (2020-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.5.2. Market Revenue and Forecast, by Sector (2020-2032)
11.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.2. Market Revenue and Forecast, by Sector (2020-2032)
11.2.3. Market Revenue and Forecast, by Application (2020-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.4.2. Market Revenue and Forecast, by Sector (2020-2032)
11.2.4.3. Market Revenue and Forecast, by Application (2020-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.5.2. Market Revenue and Forecast, by Sector (2020-2032)
11.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.6.2. Market Revenue and Forecast, by Sector (2020-2032)
11.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.2.7.2. Market Revenue and Forecast, by Sector (2020-2032)
11.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.2. Market Revenue and Forecast, by Sector (2020-2032)
11.3.3. Market Revenue and Forecast, by Application (2020-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.4.2. Market Revenue and Forecast, by Sector (2020-2032)
11.3.4.3. Market Revenue and Forecast, by Application (2020-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.5.2. Market Revenue and Forecast, by Sector (2020-2032)
11.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.6.2. Market Revenue and Forecast, by Sector (2020-2032)
11.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.3.7.2. Market Revenue and Forecast, by Sector (2020-2032)
11.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.2. Market Revenue and Forecast, by Sector (2020-2032)
11.4.3. Market Revenue and Forecast, by Application (2020-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.4.2. Market Revenue and Forecast, by Sector (2020-2032)
11.4.4.3. Market Revenue and Forecast, by Application (2020-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.5.2. Market Revenue and Forecast, by Sector (2020-2032)
11.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.6.2. Market Revenue and Forecast, by Sector (2020-2032)
11.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)
11.4.7.2. Market Revenue and Forecast, by Sector (2020-2032)
11.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.2. Market Revenue and Forecast, by Sector (2020-2032)
11.5.3. Market Revenue and Forecast, by Application (2020-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.4.2. Market Revenue and Forecast, by Sector (2020-2032)
11.5.4.3. Market Revenue and Forecast, by Application (2020-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)
11.5.5.2. Market Revenue and Forecast, by Sector (2020-2032)
11.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Eurofins Scientific
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. QIAGEN N.V.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Agilent Technologies Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Illumina Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Waters Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. NeoGenomics Laboratories
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Perkin Elmer Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Fios Genomics
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Source BioScience
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample